Q4 2020 Holdings
Filed 2021-02-16 | 43 holdings | $63.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-02-18) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $17.5M | 105,000 | 27.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $17.4M | 205,000 | 27.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.4M | 1,100,000 | 19.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.7M | 900,000 | 10.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $4.5M | 650,000 | 7.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.2M | 650,000 | 6.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $539.0K | 2,200 | 0.8% |
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $31.4K | 100,000 | 0.0% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $31.4K | 100,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $30.0K | 1,350,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $28.7K | 1,950,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $27.4K | 500,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $23.2K | 500,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $18.6K | 325,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $18.0K | 625,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $16.0K | 600,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $15.0K | 165,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $13.9K | 300,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $13.9K | 600,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $13.0K | 250,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $12.9K | 475,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)A | COM | 60468T105 | $11.0K | 50,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)CallA | COM | 60468T105 | $11.0K | 50,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.8K | 700,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $10.6K | 325,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $9.5K | 1,375,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $9.2K | 1,000,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $8.5K | 500,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.8K | 40,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $5.7K | 500,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.7K | 810,000 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $4.7K | 2,440,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $4.1K | 265,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.8K | 200,000 | 0.0% |
| Moderna Inc(MRNA)PutA | COM | 60770K107 | $3.7K | 35,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $3.7K | 35,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $3.5K | 425,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $3.2K | 200,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $2.4K | 750,000 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $2.0K | 925,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $2.0K | 400,000 | 0.0% |
| Aptevo Therapeutics Inc(APVOEUR) | COM NEW | 03835L207 | $1.8K | 50,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.6K | 200,000 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $1.3K | 200,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $922 | 200,000 | 0.0% |